The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission

Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yannan, Li, Chengwen, Zhao, Jiawei, Song, Yang, Wang, Juan, Mi, Yingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628225/
https://www.ncbi.nlm.nih.gov/pubmed/29026552
http://dx.doi.org/10.1002/ccr3.1108
_version_ 1783268839778156544
author Jia, Yannan
Li, Chengwen
Zhao, Jiawei
Song, Yang
Wang, Juan
Mi, Yingchang
author_facet Jia, Yannan
Li, Chengwen
Zhao, Jiawei
Song, Yang
Wang, Juan
Mi, Yingchang
author_sort Jia, Yannan
collection PubMed
description Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evaluation and treatment decision‐ making.
format Online
Article
Text
id pubmed-5628225
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56282252017-10-12 The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission Jia, Yannan Li, Chengwen Zhao, Jiawei Song, Yang Wang, Juan Mi, Yingchang Clin Case Rep Case Reports Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evaluation and treatment decision‐ making. John Wiley and Sons Inc. 2017-08-17 /pmc/articles/PMC5628225/ /pubmed/29026552 http://dx.doi.org/10.1002/ccr3.1108 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Jia, Yannan
Li, Chengwen
Zhao, Jiawei
Song, Yang
Wang, Juan
Mi, Yingchang
The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title_full The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title_fullStr The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title_full_unstemmed The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title_short The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
title_sort discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628225/
https://www.ncbi.nlm.nih.gov/pubmed/29026552
http://dx.doi.org/10.1002/ccr3.1108
work_keys_str_mv AT jiayannan thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT lichengwen thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT zhaojiawei thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT songyang thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT wangjuan thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT miyingchang thediscussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT jiayannan discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT lichengwen discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT zhaojiawei discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT songyang discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT wangjuan discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission
AT miyingchang discussionoft117p11q21translocationinacutepromyelocyticleukemiapatientonmolecularremission

Ejemplares similares